SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.April 3, 2015 1:04 p.m. Share
AMN Healthcare Services Inc. has acquired MillicanSolutions, a physician and executive leadership search firm focused academic medical centers and children’s hospitals.
BioNano Genomics announced Oct. 8 that it has entered a research collaboration with the University of California, Los Angeles.
PHARMA: About 40% Of Type 2 Diabetics Not Using Current Drug
Elcelyx Therapeutics has raised $40 million in a Series E financing to drive its lead drug candidate — a tweaked formulation of a popular diabetes medication — to market.
Last month, a major blow hit the biotechnology industry when political and public favor for the field suddenly slipped thanks to a highly-publicized pharmaceutical price hike. The effects of the media firestorm that followed could negatively influence the sector here at home, industry experts say.
PHARMA: Harry Hixson Takes Interim CEO Role During Search for Top Exec
Arena Pharmaceuticals’ Board of Directors has forced CEO and President Jack Lief into retirement. He is also stepping down from the board.
Scripps Health and Pioneers Memorial Healthcare District have entered into an affiliation agreement, signed Tuesday at a ceremony at Pioneers Memorial Hospital in Brawley. The two-year agreement marks the first hospital affiliation for Scripps outside of San Diego County.
San Diego’s molecular diagnostic firm BioTheranostics announced Tuesday an agreement with DeNovo Sciences to investigate the feasibility of using BioTheranostics’ proprietary biomarkers for blood-based cancer diagnostics.
Tracon Pharmaceuticals, a public biopharmaceutical company in San Diego, announced Tuesday that Dr. Ronald Shazer has been appointed chief medical officer.
Arena Pharmaceuticals Inc. announced that its CEO and President, Jack Lief, has retired from the company at the request of the board of directors. He is also stepping down from the board.
Sequenom Inc. announced Monday that it has entered into a clinical collaboration with Seoul National University Hospital.
Tokalas Inc. on Monday announced the appointment of Dr. James B. Breitmeyer to the position of president and chief executive officer.
San Diego-based Orexigen Therapeutics Inc. announced that it has filed a new drug application with the Ministry of Food and Drug Safety in South Korea for Contrave as a monotherapy for weight management in overweight and obese adult patients.
San Diego-based Elcelyx Therapeutics announced Sept. 30 that it has secured $40 million in a Series E financing.
San Diego health IT firm Entra Health announced Oct. 1 the launch of a new video consult application.
Lpath Inc. announced that Gary Atkinson has been appointed interim chief executive officer of Lpath, effective immediately.